These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10612355)

  • 1. Basic mechanisms of gabitril (tiagabine) and future potential developments.
    Meldrum BS; Chapman AG
    Epilepsia; 1999; 40 Suppl 9():S2-6. PubMed ID: 10612355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.
    Borden LA; Murali Dhar TG; Smith KE; Weinshank RL; Branchek TA; Gluchowski C
    Eur J Pharmacol; 1994 Oct; 269(2):219-24. PubMed ID: 7851497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabine in vitro.
    Sabau A; Frahm C; Pfeiffer M; Breustedt J; Piechotta A; Numberger M; Engel D; Heinemann U; Draguhn A
    Eur J Pharmacol; 1999 Nov; 383(3):259-66. PubMed ID: 10594317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1.
    Dalby NO; Thomsen C; Fink-Jensen A; Lundbeck J; Søkilde B; Man CM; Sørensen PO; Meldrum B
    Epilepsy Res; 1997 Jul; 28(1):51-61. PubMed ID: 9255599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor.
    Suzdak PD; Jansen JA
    Epilepsia; 1995 Jun; 36(6):612-26. PubMed ID: 7555976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel GABA uptake inhibitors. 3. Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents.
    Knutsen LJ; Andersen KE; Lau J; Lundt BF; Henry RF; Morton HE; Naerum L; Petersen H; Stephensen H; Suzdak PD; Swedberg MD; Thomsen C; Sørensen PO
    J Med Chem; 1999 Sep; 42(18):3447-62. PubMed ID: 10479278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laminar difference in GABA uptake and GAT-1 expression in rat CA1.
    Engel D; Schmitz D; Gloveli T; Frahm C; Heinemann U; Draguhn A
    J Physiol; 1998 Nov; 512 ( Pt 3)(Pt 3):643-9. PubMed ID: 9769410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular regulation of glutamate and GABA transporter proteins by valproic acid in rat hippocampus during epileptogenesis.
    Ueda Y; Willmore LJ
    Exp Brain Res; 2000 Aug; 133(3):334-9. PubMed ID: 10958523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze.
    Schmitt U; Hiemke C
    Behav Pharmacol; 1999 Mar; 10(2):131-7. PubMed ID: 10780826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of substituted triarylnipecotic acid derivatives as GABA uptake inhibitors: identification of a ligand with moderate affinity and selectivity for the cloned human GABA transporter GAT-3.
    Dhar TG; Borden LA; Tyagarajan S; Smith KE; Branchek TA; Weinshank RL; Gluchowski C
    J Med Chem; 1994 Jul; 37(15):2334-42. PubMed ID: 8057281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy.
    Morimoto K; Sato H; Yamamoto Y; Watanabe T; Suwaki H
    Epilepsia; 1997 Sep; 38(9):966-74. PubMed ID: 9579934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First demonstration of a functional role for central nervous system betaine/{gamma}-aminobutyric acid transporter (mGAT2) based on synergistic anticonvulsant action among inhibitors of mGAT1 and mGAT2.
    White HS; Watson WP; Hansen SL; Slough S; Perregaard J; Sarup A; Bolvig T; Petersen G; Larsson OM; Clausen RP; Frølund B; Falch E; Krogsgaard-Larsen P; Schousboe A
    J Pharmacol Exp Ther; 2005 Feb; 312(2):866-74. PubMed ID: 15550575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of background GABA uptake in rat hippocampal slices.
    Frahm C; Engel D; Draguhn A
    Neuroreport; 2001 Jun; 12(8):1593-6. PubMed ID: 11409722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors.
    Dalby NO
    Neuropharmacology; 2000 Sep; 39(12):2399-407. PubMed ID: 10974324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tiagabine pharmacology in profile.
    Brodie MJ
    Epilepsia; 1995; 36 Suppl 6():S7-S9. PubMed ID: 8595791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiagabine: a novel drug with a GABAergic mechanism of action.
    Gram L
    Epilepsia; 1994; 35 Suppl 5():S85-7. PubMed ID: 8039478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of valproate, vigabatrin and tiagabine on GABA uptake into human astrocytes cultured from foetal and adult brain tissue.
    Fraser CM; Sills GJ; Butler E; Thompson GG; Lindsay K; Duncan R; Howatson A; Brodie MJ
    Epileptic Disord; 1999 Sep; 1(3):153-7. PubMed ID: 10937147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiagabine, a specific gamma-aminobutyric acid transporter-1 inhibitor, in the treatment of psychosis.
    Sharma RP; Martis B; Davis JM; Omens R; Janicak PG
    J Clin Psychopharmacol; 2001 Jun; 21(3):347-9. PubMed ID: 11386503
    [No Abstract]   [Full Text] [Related]  

  • 19. Tiagabine.
    Mengel H
    Epilepsia; 1994; 35 Suppl 5():S81-4. PubMed ID: 8039477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of gamma-aminobutyric acid uptake: anatomy, physiology and effects against epileptic seizures.
    Dalby NO
    Eur J Pharmacol; 2003 Oct; 479(1-3):127-37. PubMed ID: 14612144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.